Peter on the importance of cancer screenings
This video clip is from AMA #25: Navigating the complexities and nuances of cancer screening, originally released on July 26,…
#196 – AMA #32: Exercise, squats, deadlifts, BFR, and TRT
“You have to differentiate between signal and noise. . .it’s easy to say testosterone causes heart disease just like it’s easy to say estrogen causes breast cancer. But if you’re actually going to go through all of the data. . .I think it becomes very difficult to make that case.” —Peter Attia
#181 – Robert Gatenby, M.D.: Viewing cancer through an evolutionary lens and why this offers a radically different approach to treatment
“For a century we’ve been looking for magic bullets, but maybe all we need is a series of pretty good bullets.” —Bob Gatenby
#170 – AMA #25: Navigating the complexities and nuances of cancer screening
“We screen often, we screen early, and we screen aggressively.” —Peter Attia
#121 – Azra Raza, M.D.: Why we’re losing the war on cancer
“We are living in an era of the most sophisticated technological advances possible, and yet the treatment of cancer is paleolithic.” — Azra Raza
#120 – AMA with Dom D’Agostino, Ph.D., Part II of II: Ketosis for cancer and chronic disease, hyperbaric oxygen therapy, and the effect of ketosis on female health
“The function of the mitochondria and mitochondrial health are the ultimate mitigator of neurodegenerative diseases…just by reducing the potential for reactive oxygen species related damage.” — Dom D’Agostino
#110 – Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K
“If I get a result that suddenly doesn’t make sense, to me that’s more exciting. . .if you figure out why it didn’t work and what was wrong, then that’s where most breakthroughs come from.” — Lew Cantley
Hormone therapy and breast cancer?
There are not many topics in clinical medicine more polarizing than hormone replacement therapy (HRT) for women suffering from menopausal…
#62 – Keith Flaherty, M.D.: Deep dive into cancer— History of oncology, novel approaches to treatment, and the exciting and hopeful future
“We can’t keep hitting the same pillar and expect that we’re going to cure cancer. . .we need the activators of the immune system, we need the inhibitors of the activated oncogenes, we need the drugs that target epigenetic regulators, and we need the metabolic switch regulators.” — Keith Flaherty
#61 – Rajpaul Attariwala, M.D., Ph.D.: Cancer screening with full-body MRI scans and a seminar on the field of radiology
“This is where an MRI becomes a beautiful machine in the fact that it actually allows you to take the ‘yes or no’ binary answer of functional nuclear medicine and combine it with the anatomic localization and understanding of tissue types of radiology. . .I merged those two together on the one machine.” — Raj Attariwala